Health Care·Health Care Technology·$1.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.76 | N/A | -85.36% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.76 | N/A | -85.36% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about current performance but remains committed to future growth strategies. They did not provide specific guidance for upcoming quarters.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on long-term growth despite short-term setbacks.
Teladoc Health's earnings report indicates significant challenges, particularly reflected in the EPS miss. The stock dropped 3.24% in response, suggesting investor concern over the company's current performance and lack of guidance. The management's defensive tone may signal ongoing difficulties in achieving profitability in the near term.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
RB GLOBAL INC
Feb 26, 2018